Monday, January 30, 2023
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
Daily Remedy
  • Home
  • Articles
  • Podcasts
    A conversation with Dr. Selwyn O. Rogers, trauma surgeon and gun policy expert

    A conversation with Dr. Selwyn O. Rogers, trauma surgeon and gun policy expert

    November 25, 2022
    A conversation with Dr. Kyle Fischer, policy director for the Health Alliance for Violence Intervention

    A conversation with Dr. Kyle Fischer, policy director for the Health Alliance for Violence Intervention

    November 25, 2022
    A conversation with Dr. Edwin Leap, physician writer and emergency medicine physician

    A conversation with Dr. Edwin Leap, writer and emergency medicine physician

    November 8, 2022
    A conversation with Mr. Omar M Khateeb, innovator in medical device sales

    A conversation with Mr. Omar M Khateeb, innovator in medical device sales

    October 31, 2022
    A conversation with Miss Smriti Kirubanandan, passionate healthcare strategist

    A conversation with Miss Smriti Kirubanandan, passionate healthcare strategist

    October 23, 2022
    A conversation with Mr. Michael Johnson, legal expert in physician contracts

    A conversation with Mr. Michael Johnson, legal expert in physician contracts

    October 23, 2022
  • Surveys

    Surveys

    Does inflation affect how you use your deductible?

    Does inflation affect how you use your deductible?

    by Jay K Joshi
    December 12, 2022

    Survey Resutls

    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    October 16, 2022
  • About Us
  • Contact us
  • Support Us
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    A conversation with Dr. Selwyn O. Rogers, trauma surgeon and gun policy expert

    A conversation with Dr. Selwyn O. Rogers, trauma surgeon and gun policy expert

    November 25, 2022
    A conversation with Dr. Kyle Fischer, policy director for the Health Alliance for Violence Intervention

    A conversation with Dr. Kyle Fischer, policy director for the Health Alliance for Violence Intervention

    November 25, 2022
    A conversation with Dr. Edwin Leap, physician writer and emergency medicine physician

    A conversation with Dr. Edwin Leap, writer and emergency medicine physician

    November 8, 2022
    A conversation with Mr. Omar M Khateeb, innovator in medical device sales

    A conversation with Mr. Omar M Khateeb, innovator in medical device sales

    October 31, 2022
    A conversation with Miss Smriti Kirubanandan, passionate healthcare strategist

    A conversation with Miss Smriti Kirubanandan, passionate healthcare strategist

    October 23, 2022
    A conversation with Mr. Michael Johnson, legal expert in physician contracts

    A conversation with Mr. Michael Johnson, legal expert in physician contracts

    October 23, 2022
  • Surveys

    Surveys

    Does inflation affect how you use your deductible?

    Does inflation affect how you use your deductible?

    by Jay K Joshi
    December 12, 2022

    Survey Resutls

    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    October 16, 2022
  • About Us
  • Contact us
  • Support Us
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Politics & Law

We Have More, but Fewer COVID-19 Treatments

Jay K Joshi by Jay K Joshi
January 9, 2022
in Politics & Law
0
We Have More, but Fewer COVID-19 Treatments

For many, Omicron presents an eerie sense of déjà vu. It feels like we are returning to the beginning of the pandemic.

But there are two critical differences. The first is the vaccines. But the second may prove to be more beneficial in the coming weeks – the treatments.

We now have more proven COVID-19 treatments than at the beginning of the pandemic, but they remain curiously scarce despite calls from policy experts to increase availability. Some of the latest treatments are even designed for at-home use, ostensibly to reduce the need for hospitalization, the principal metric used to determine COVID-19 impact.

These treatments have the potential to reduce the clinical and economic burden of Omicron, particularly since the variant can evade both natural and vaccine acquired immunity. But the Food and Drug Administration (FDA) has limited manufacturing to date, even for emergency use.

Within the limited supply authorized by the FDA, each state can allocate its own system for distributing and administering the treatment. For example, in Indiana, certain treatments will go to only designated hospitals and pharmacies. All of which is to say these treatments will be hard to find.

Which is a shame, because these treatments can combat severe COVID-19 cases among high risk populations and breakthrough COVID-19 cases among the fully vaccinated. Many healthcare workers on the frontlines of COVID-19 will tell you that no one treatment has proven consistently effective. They need as many tools as possible at their disposal. In this vein, limiting proven treatments seems to be an odd decision – until you consider the full context.

“None of these therapies that [we are] talking about, whether [it is] antibodies or the pills, are anywhere near as effective as vaccination”, said Dr. Helen Boucher, interim dean of Tufts Medical School. Her statement reveals more than she likely had intended. For it belies the lingering belief among public health leaders that more readily available treatments will lead to lower vaccination rates.

While never explicitly framed as such, this belief among the powers that be is responsible for the limited number of treatments. But coupling vaccines with treatments reduces the care for COVID-19 patients into a dichotomy – either vaccines or treatments.

It becomes a zero sum game. One comes at the expense of the other, which might have been true when vaccination rates were low and most available treatments were speculative.

But Omicron presents a unique dilemma. This late into the pandemic, the game has changed because it is no longer zero sum. It is varying shades of gray – meaning the optimal patient outcome might be getting vaccinated and having access to treatment.

The rules of the game should not be defined by constraints on the number of treatments available, but by clinical need. If a patient, regardless of underlying risk, benefits from treatment, then he or she should have access to it. Stratify treatment availability according to clinical need and vaccination status, assuming one or both may be needed in the course of treating patients.

COVID-19 is a long term condition and people previously treated or vaccinated may be infected again. All treatment options and vaccines must be available as they are needed since the clinical conditions for many patients change over time.

Yet policy makers remain affixed to the notion that more available treatments will reduce vaccination rates – and therefore fewer treatments will increase vaccination rates – and through such faulty logic have created a veritable prohibition on COVID-19 treatments.

But reducing the discussion around vaccines and treatments into a dichotomy presents an interesting conundrum – how to balance the perception of treatments with the clinical need for them?

Unfortunately, it seems that the perception will outweigh the need and that the ones who will suffer are the patients. In that sense, we are right. This is déjà vu. We are returning to the beginning of the pandemic.

ShareTweet
Jay K Joshi

Jay K Joshi

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

YouTube Video VVUxUDVQenU5RTFjUVFKNDY2ZlBmdFB3LmdVUm55WVpqRmNn This is a video about Elemental/Essential Frameworks of Healthcare Law

00:00 Elemental/Essential Frameworks of Healthcare Law
Load More... Subscribe

Expert vs. Lay Testimony

Visuals

NADAC (National Average Drug Acquisition Cost)

NADAC (National Average Drug Acquisition Cost)

by Jay K Joshi
January 29, 2023
0

We list the acquisition price of drugs that are covered under the Medicaid Drug Rebate Program - effectively, how much does the government pay for common drugs utilized by patients on Medicaid. Drugs listed are from A-CH.  

Read more

Twitter Updates

Tweets by DailyRemedy1

Newsletter

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do

Popular

  • Letter to the Alabama Board of Medical Examiners

    Letter to the Alabama Board of Medical Examiners

    0 shares
    Share 0 Tweet 0
  • Prosecuting Doctors as Drug Dealers

    0 shares
    Share 0 Tweet 0
  • Why Our Prescribing were for Patients’ Best Interests

    0 shares
    Share 0 Tweet 0
  • My Respect for the Law

    0 shares
    Share 0 Tweet 0
  • DEA Sets CDC Opioid Guidelines

    0 shares
    Share 0 Tweet 0

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Newsletter

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2023 Daily Remedy

No Result
View All Result
  • Home
  • Articles
    • Contrarian
    • Financial Markets
    • Innovations & Investing
    • Perspectives
    • Politics & Law
    • Trends
    • Uncertainty & Complexity
  • Podcasts
  • Surveys
    • Survey Results
  • About Us
  • Contact us
  • Support Us

© 2023 Daily Remedy

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do